Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBlood calcium levels are not directly affected by tirzepatide in a clinically meaningful way under normal use — that much the current evidence supports. Mounjaro is not known to alter calcium metabolism as part of its mechanism, and the medicine's prescribing information does not flag hypercalcaemia or hypocalcaemia as recognised effects. That said, some people starting tirzepatide do notice symptoms (fatigue, muscle cramps, general 'off' feelings) that prompt them to wonder whether their calcium, or other markers, have shifted. If you're in that position, it's worth understanding what Mounjaro actually does to body chemistry, what might genuinely explain those symptoms, and when a blood test or a conversation with a prescriber makes sense. These are prescription-only medicines, and any concern about specific blood values should go to a clinician who can look at your full picture, not just one number.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a reasonable thing to wonder. Muscle cramps, pins and needles, and fatigue are exactly the kind of vague physical symptoms that get attributed to calcium when someone is also taking a new medicine. The short answer is that tirzepatide does not act on the parathyroid gland or the mechanisms that regulate serum calcium. Its dual GIP and GLP-1 receptor activity is focused on appetite, gastric emptying, and blood-glucose signalling, a quite different set of pathways from those governing mineral homeostasis.
That distinction matters because it changes where you look for an explanation. The SURMOUNT clinical programme, which studied tirzepatide extensively in thousands of adults, did not report dysregulated calcium as a recognised effect. The NHS medicines information for tirzepatide lists the known side effects, and calcium disturbance is not among them. What IS in that list: nausea, diarrhoea, vomiting, constipation, reduced appetite, and fatigue. Each of those can produce secondary consequences, repeated vomiting or diarrhoea, for instance, causes fluid and electrolyte losses that could theoretically nudge various lab values, including magnesium, potassium, and yes, calcium, though this would be a downstream effect of dehydration rather than a direct drug effect.
If you're experiencing persistent or severe cramps, the more plausible explanations are: inadequate fluid intake, reduced overall dietary intake (affecting magnesium and potassium as much as calcium), or the general adjustment phase that many people go through in the first few weeks after starting or increasing a dose. Dehydration deserves particular attention, it's covered in detail on our page about how Mounjaro can affect energy levels, where the knock-on effects of GI symptoms are unpacked.
Here is where the indirect picture is worth thinking about seriously. Tirzepatide is notably effective at reducing appetite (that's much of the point) and people who are eating substantially less than before face a genuine micronutrient challenge. Calcium is no exception. Adults in the UK are advised to get around 700mg of calcium daily (primarily from dairy, fortified foods, dark leafy greens, and nuts), and if total food intake drops sharply, that target becomes harder to meet through diet alone.
This is not a Mounjaro-specific problem. Any significant calorie restriction, whatever the cause, raises the same question about adequacy. Clinical guidance consistently suggests that people on weight-management medicines pay attention to protein, fibre, hydration, and overall micronutrient intake rather than treating any one mineral as the one to watch. A registered dietitian or your prescriber is best placed to assess whether supplementation makes sense for your diet and circumstances, this is genuinely not a one-size determination.
Vitamin D is worth a brief mention here because it directly governs calcium absorption. Low vitamin D is common in the UK population regardless of whether someone is taking tirzepatide, and inadequate vitamin D will impair calcium uptake from food even if dietary calcium is plentiful. The NHS recommends that most adults in the UK consider a daily vitamin D supplement, particularly from October to March. If calcium symptoms concern you, vitamin D status is a sensible first thing to check, more likely to be the lever than tirzepatide itself.
For a fuller picture of how Mounjaro interacts with body chemistry more broadly, the page on Mounjaro and cortisol levels covers the hormonal-stress axis, and questions about other specific markers are addressed across our Mounjaro levels resource.
Routine calcium monitoring is not part of standard tirzepatide prescribing in the UK under current guidance. That said, there are situations where checking makes good sense. If you have a pre-existing condition that already affects calcium regulation (hypoparathyroidism, chronic kidney disease, malabsorption conditions, or long-term use of medicines that interact with mineral metabolism) you should discuss this with your prescriber before starting or continuing tirzepatide. Certain medicines taken alongside tirzepatide can affect electrolyte balance; our page on Mounjaro and lithium illustrates the kind of interaction monitoring that becomes relevant when specific drugs are involved.
Seek prompt medical attention (not a future GP appointment, but the same day) if you experience: severe muscle weakness or cramps that don't settle; numbness or tingling around the mouth or in the hands and feet that is new and persistent; an irregular heartbeat; or any combination of symptoms suggesting significant dehydration after prolonged vomiting or diarrhoea. These could point to a genuine electrolyte imbalance that needs a blood test to characterise. You can also report any suspected side effect of Mounjaro directly using the MHRA's Yellow Card scheme, it's open to patients, not just healthcare professionals, and every report contributes to the post-market safety picture for medicines that are still under additional MHRA monitoring.
If your symptoms are milder (occasional cramps, low energy, general fatigue) and you're a few weeks into treatment, the first step is usually to look at hydration, protein intake, and whether you're eating enough variety rather than heading straight for a supplement. Small practical changes often resolve this. And if they don't, your prescriber can request a routine blood panel that will answer the calcium question definitively rather than leaving you guessing.
Concerns about blood results, nutrient levels, or how tirzepatide is interacting with your body are exactly the kind of thing a prescriber should hear about, not because every symptom is serious, but because a clinician can contextualise a number in a way that a search result cannot. If you're travelling while on treatment and want practical guidance on getting Mounjaro through airport security, we have a dedicated page covering exactly what to expect at the checkpoint. If you're already on Mounjaro through another route and want to understand whether transferring to a service with regular prescriber oversight would help, it's worth looking at how regulated online prescribing works in the UK.
At nume, every prescription is reviewed personally by a GPhC-registered Independent Prescriber, not software, not a triage algorithm. That includes repeat orders, where evidence of response and any emerging concerns are considered before treatment continues. If you have a question about calcium, lab values, or anything else relating to your health and tirzepatide, our team can be reached through our contact page seven days a week.
Tirzepatide is a prescription-only medicine. The cost context for private treatment is explained on our treatment overview page, and if you're wondering whether now is the right moment to start (whether that's shaped by a bank holiday, a Monday payday, or something else entirely), a consultation is free and there's no obligation. Speak to our prescribers and get a clear answer based on your actual health picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.